1 |
CHRM3
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Tolterodine
Tolterodine
💬
|
Tolterodine
| 2件: 17 17, 53 💬 |
2 |
COMT
💬
| 4件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse | Entacapone
Entacapone
💬
|
Entacapone
| 2件: 6 6, 17 💬 |
3 |
ADRA1D
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
4 |
ADRA1D
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Midodrine
Midodrine
💬
|
Midodrine
| 3件: 6 6, 17, 58 💬 |
5 |
ADRA1D
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
6 |
ADRA1B
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
7 |
ADRA1B
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Midodrine
Midodrine
💬
|
Midodrine
| 3件: 6 6, 17, 58 💬 |
8 |
ADRA1B
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
9 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
10 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Midodrine
Midodrine
💬
|
Midodrine
| 3件: 6 6, 17, 58 💬 |
11 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
12 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
13 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
14 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
15 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
16 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
17 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
18 |
ADRB1
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
19 |
ADRB1
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Metoprolol
Metoprolol
💬
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 💬 |
20 |
ADRB1
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Nebivolol
Nebivolol
💬
|
Nebivolol
| 4件: 17 17, 85, 113, 167 💬 |
21 |
ADRB1
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
22 |
ADRB2
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
23 |
ADRB2
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
24 |
ADRB3
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Droxidopa
Droxidopa
💬
|
Droxidopa
| 5件: 5 5, 6, 17, 169, 170 💬 |
25 |
ADRB3
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Pseudoephedrine
Pseudoephedrine
💬
|
Pseudoephedrine
| 1件: 17 17 💬 |
26 |
ACE
💬
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy | Captopril
Captopril
💬
|
Captopril
| 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 💬 |
27 |
DDC
💬
| 9件: Tyrosine metabolism Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism | Carbidopa
Carbidopa
💬
|
Carbidopa
| 7件: 6 6, 13, 17, 90, 140, 164, 201 💬 |
28 |
DRD1
💬
| 10件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | Levodopa
Levodopa
💬
|
Levodopa
| 6件: 6 6, 17, 90, 140, 164, 201 💬 |
29 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Levodopa
Levodopa
💬
|
Levodopa
| 6件: 6 6, 17, 90, 140, 164, 201 💬 |
30 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Domperidone
Domperidone
💬
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 💬 |
31 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Domperidone maleate
Domperidone maleate
💬
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 💬 |
32 |
DRD3
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | Levodopa
Levodopa
💬
|
Levodopa
| 6件: 6 6, 17, 90, 140, 164, 201 💬 |
33 |
DRD4
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | Levodopa
Levodopa
💬
|
Levodopa
| 6件: 6 6, 17, 90, 140, 164, 201 💬 |
34 |
DRD5
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse | Levodopa
Levodopa
💬
|
Levodopa
| 6件: 6 6, 17, 90, 140, 164, 201 💬 |
35 |
AGTR1
💬
| 16件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy | Angiotensin II
Angiotensin II
💬
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 💬 |
36 |
AGTR1
💬
| 16件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy | Angiotensin II
Angiotensin II
💬
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 💬 |
37 |
AGTR1
💬
| 16件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy | Losartan
Losartan
💬
|
Losartan
| 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
38 |
AGTR2
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system | Angiotensin II
Angiotensin II
💬
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 💬 |
39 |
AGTR2
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system | Angiotensin II
Angiotensin II
💬
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 💬 |
40 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
41 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
42 |
MTOR
💬
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, Autophagy - other, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Apelin signaling pathway, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Th17 cell differentiation, Thermogenesis, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Growth hormone synthesis, secretion and action, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Pancreatic cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Diabetic cardiomyopathy | Sirolimus
Sirolimus
💬
|
Sirolimus
| 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬 |
43 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
44 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
45 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
46 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
47 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
48 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
49 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
50 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
51 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
52 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
53 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
54 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
55 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
56 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
57 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
58 |
GLP1R
💬
| 3件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion | Exenatide
Exenatide
💬
|
Exenatide
| 6件: 6 6, 17, 72, 78, 193, 233 💬 |
59 |
GRIA1
💬
| 14件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
60 |
GRIA2
💬
| 15件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
61 |
GRIA3
💬
| 13件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction, Transcriptional misregulation in cancer | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
62 |
GRIA4
💬
| 10件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Huntington disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
63 |
GRIK1
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
64 |
GRIK2
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
65 |
GRIK3
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
66 |
GRIK4
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
67 |
GRIK5
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
68 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
69 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
70 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
71 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
72 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
73 |
MAOB
💬
| 14件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Alcoholism | Rasagiline
Rasagiline
💬
|
Rasagiline
| 6件: 2 2, 5, 6, 17, 58, 66 💬 |
74 |
MAOB
💬
| 14件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Alcoholism | Safinamide
Safinamide
💬
|
Safinamide
| 2件: 6 6, 17 💬 |
75 |
MAOB
💬
| 14件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Alcoholism | Rasagiline tartrate
Rasagiline tartrate
💬
|
Rasagiline
| 6件: 2 2, 5, 6, 17, 58, 66 💬 |
76 |
NR3C2
💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption | Fludrocortisone
Fludrocortisone
💬
|
Fludrocortisone
| 3件: 6 6, 17, 81 💬 |
77 |
MPO
💬
| 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Phagosome, Neutrophil extracellular trap formation, Transcriptional misregulation in cancer, Acute myeloid leukemia | Verdiperstat
Verdiperstat
💬
|
Verdiperstat
| 3件: 2 2, 17, 127 💬 |
78 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
79 |
SLC6A2
💬
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Atomoxetine
Atomoxetine
💬
|
Atomoxetine
| 4件: 6 6, 8, 13, 17 💬 |
80 |
SLC6A2
💬
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Ampreloxetine
Ampreloxetine
💬
|
Ampreloxetine
| 2件: 6 6, 17 💬 |
81 |
SLC6A4
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Fluoxetine
Fluoxetine
💬
|
Fluoxetine
| 6件: 13 13, 17, 78, 86, 179, 206 💬 |
82 |
SLC6A4
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Ampreloxetine
Ampreloxetine
💬
|
Ampreloxetine
| 2件: 6 6, 17 💬 |
83 |
SNAP25
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | Botulinum toxin type A
Botulinum toxin type A
💬
|
Botulinum toxin type A
| 14件: 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬 |